In 2024, the trade exchange (includes international purchases and sales) of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) was US$20.4M.
In 2024, the states with the most international sales in Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) were Jalisco (US$392k).
The states with the most international purchases in 2024 were Jalisco (US$11.1M) and Ciudad de México (US$5.87M).
In 2024, the main commercial destinations of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) were Brazil (US$203k), Guatemala (US$121k), Costa Rica (US$53.5k), and Nicaragua (US$14.5k).
The main commercial origins of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) in 2024 were China (US$11.7M), India (US$2.19M), Brazil (US$1.47M), Taiwan (Republic of China) (US$655k), and Pakistan (US$337k).
In the global context, the main exporting countries of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) in 2022 were China (US$289M), Italy (US$269M), and Jordan (US$44.6M). In the same year, the main importing countries of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) were Switzerland (US$210M), United States (US$57.1M), and Germany (US$47.2M).